NPSP INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation of the Board of Directors of NPS Pharmaceuticals Inc. C...
January 14 2015 - 12:01PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
NPS Pharmaceuticals Inc. (“NPS Pharmaceuticals” or “the Company”)
(NASDAQGS: NPSP) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to Shire plc.
Click here to learn more about the investigation:
http://zlk.9nl.com/nps-pharmaceuticals-npsp.
Under the terms of the transaction, NPS Pharmaceuticals
shareholders will receive $46 in cash for each share of NPS
Pharmaceuticals stock they own. The investigation concerns whether
the Board of NPS Pharmaceuticals breached their fiduciary duties to
stockholders by failing to adequately shop the Company before
agreeing to enter into this transaction, and whether Shire plc is
underpaying for NPS Pharmaceuticals shares.
If you own NPS Pharmaceuticals common stock and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/nps-pharmaceuticals-npsp.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Oct 2023 to Oct 2024